Senvelgo represents a shift in feline diabetic care, moving away from twice-daily insulin injections to a manageable once-daily oral dose. Developed by Boehringer Ingelheim, it is specifically formulated to be palatable for cats while providing effective glycaemic control, often within the first week of treatment.
Why Choose Senvelgo
Ease of Use: Simple oral administration via syringe.
No Refrigeration: Ideal for travel and easy home storage.
Precise Dosing: Syringe markings based on body weight ensure accuracy.
Clinically Proven: High efficacy in managing non-insulin-dependent diabetes.